Michael Coleman
Affiliations: | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"Michael Coleman"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Loreto A, Merlini E, Coleman MP. (2024) Programmed axon death: a promising target for treating retinal and optic nerve disorders. Eye (London, England) |
| Yang S, Niou ZX, Enriquez A, et al. (2024) NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Molecular Neurodegeneration. 19: 13 |
| Groh J, Abdelwahab T, Kattimani Y, et al. (2023) Microglia-mediated demyelination protects against CD8 T cell-driven axon degeneration in mice carrying PLP defects. Nature Communications. 14: 6911 |
| Mutschler C, Fazal SV, Schumacher N, et al. (2023) Schwann cells are axo-protective after injury irrespective of myelination status in mouse Schwann cell-neuron cocultures. Journal of Cell Science. 136 |
| Yang S, Niou ZX, Enriquez A, et al. (2023) NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Research Square |
| Fazal SV, Mutschler C, Chen CZ, et al. (2023) SARM1 detection in myelinating glia: / is dispensable for PNS and CNS myelination in zebrafish and mice. Frontiers in Cellular Neuroscience. 17: 1158388 |
| Loreto A, Antoniou C, Merlini E, et al. (2023) NMN: The NAD Precursor at the Intersection Between Axon Degeneration and Anti-ageing Therapies. Neuroscience Research |
| Llobet Rosell A, Paglione M, Gilley J, et al. (2022) The NAD precursor NMN activates dSarm to trigger axon degeneration in . Elife. 11 |
| Coleman MP. (2022) Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 19: 1133-1144 |
| Ademi M, Yang X, Coleman MP, et al. (2022) Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survival. Scientific Reports. 12: 13846 |